Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiography
Sign Up to like & getrecommendations! Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-021-05163-7
Abstract: To analyze the evolution of type 3 neovascularization in eyes with age-related macular degeneration during anti-vascular endothelial growth factor (VEGF) treatment using optical coherence tomography angiography (OCTA) analysis. Forty-one treatment-naïve eyes (37 patients) with type… read more here.
Keywords: age related; related macular; evolution type; type neovascularization ... See more keywords
EFFICACY AND SAFETY OF A TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH TYPE 3 NEOVASCULARIZATION: A 52-Week, Single-Arm, Multicenter Trial.
Sign Up to like & getrecommendations! Published in 2019 at "Retina"
DOI: 10.1097/iae.0000000000002582
Abstract: PURPOSE To evaluate 52-week efficacy and safety of a treat-and-extend regimen of intravitreal aflibercept 2 mg on treatment-naive Type 3 neovascularization lesions. METHODS Phase IV, prospective, open-label, single-arm, multicenter trial including patients with untreated Stage… read more here.
Keywords: extend regimen; treatment; type neovascularization; treat extend ... See more keywords
One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 Neovascularization
Sign Up to like & getrecommendations! Published in 2019 at "Ophthalmologica"
DOI: 10.1159/000499719
Abstract: Purpose: To evaluate the effect of intravitreal aflibercept injections in treatment-naive type 3 neovascularization using a fixed treatment regime during the first year of therapy. Methods: Fourteen eyes of 14 patients diagnosed with type 3… read more here.
Keywords: treatment regime; treatment; year; type neovascularization ... See more keywords
Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2019.03.20
Abstract: AIM To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization. METHODS This retrospective study included 137 eyes that were newly diagnosed… read more here.
Keywords: visual loss; type neovascularization; abrupt visual; loss ... See more keywords